Kyle Diamantas Appointed as Acting Commissioner of the FDA

Diamantas' appointment raises questions about the intersection of corporate interests and public health, especially given his previous legal work defending a formula maker. His experience in the FDA may provide a unique perspective on food safety and regulation, but it also presents potential conflicts of interest. Observers will be keen to see how his leadership will influence FDA policies, particularly in areas concerning infant health and safety.